Huadong Medicine is a Manufacturer/Innovator, Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry.
Huadong medicine was established in 1993, headquartered in Hangzhou, China, is China’s top 10 listed pharmaceutical and medical companies. The Company has more than 12,000 employees. In 2021, the Company’s revenue stood at about 5.3billion USD. Huadong medicine are manufactuers of finished medicine, APIs and aesthetic medicine.We can provide immunosuppressant, antidiabetic, anti-infection, anti-tumor APIs and ADC toxins, Protected & modified nucleoside/nucleotide for Oligonucleotide and mRNA drugs. Our main products include: Mupirocin,Tacrolimus….
Company type
Manufacturer/Innovator, Generics/Biosimilars Manufacturer
Products and services
Biopharmaceuticals, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Huadong Medicine, No. 866 Moganshan Road, Hangzhou, Zhejiang, China, 310015
